BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9841877)

  • 21. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
    Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
    J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes.
    Ohmi Y; Nishikaze T; Kitaura Y; Ito T; Yamamoto S; Sugiyama F; Matsuyama M; Takahashi Y; Takeda A; Kawahara T; Okajima T; Furukawa K; Furukawa K
    Glycobiology; 2021 Jun; 31(5):557-570. PubMed ID: 33242079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycoproteins from insect cells: sialylated or not?
    Marchal I; Jarvis DL; Cacan R; Verbert A
    Biol Chem; 2001 Feb; 382(2):151-9. PubMed ID: 11308014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
    Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
    J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.
    Cohen O; Kronman C; Chitlaru T; Ordentlich A; Velan B; Shafferman A
    Biochem J; 2001 Aug; 357(Pt 3):795-802. PubMed ID: 11463350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
    Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
    Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
    Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.
    Macauley MS; Arlian BM; Rillahan CD; Pang PC; Bortell N; Marcondes MC; Haslam SM; Dell A; Paulson JC
    J Biol Chem; 2014 Dec; 289(51):35149-58. PubMed ID: 25368325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
    Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
    Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
    Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
    J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the coordinated role of ST3GAL3, ST3GAL4 and ST3GAL6 on the α2,3 sialylation linkage of mammalian glycoproteins.
    Chung CY; Yin B; Wang Q; Chuang KY; Chu JH; Betenbaugh MJ
    Biochem Biophys Res Commun; 2015 Jul; 463(3):211-5. PubMed ID: 25998389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
    Naso MF; Tam SH; Scallon BJ; Raju TS
    MAbs; 2010; 2(5):519-27. PubMed ID: 20716959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins.
    Weikert S; Papac D; Briggs J; Cowfer D; Tom S; Gawlitzek M; Lofgren J; Mehta S; Chisholm V; Modi N; Eppler S; Carroll K; Chamow S; Peers D; Berman P; Krummen L
    Nat Biotechnol; 1999 Nov; 17(11):1116-21. PubMed ID: 10545921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-glycan sialylation in a silkworm-baculovirus expression system.
    Suganuma M; Nomura T; Higa Y; Kataoka Y; Funaguma S; Okazaki H; Suzuki T; Fujiyama K; Sezutsu H; Tatematsu KI; Tamura T
    J Biosci Bioeng; 2018 Jul; 126(1):9-14. PubMed ID: 29433940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
    Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
    EBioMedicine; 2024 Jun; 104():105163. PubMed ID: 38772281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging.
    Tadokoro T; Yamamoto K; Kuwahara I; Fujisawa H; Ikekita M; Taniguchi A; Sato T; Furukawa K
    Glycoconj J; 2006 Jul; 23(5-6):443-52. PubMed ID: 16897185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelets support extracellular sialylation by supplying the sugar donor substrate.
    Lee MM; Nasirikenari M; Manhardt CT; Ashline DJ; Hanneman AJ; Reinhold VN; Lau JT
    J Biol Chem; 2014 Mar; 289(13):8742-8. PubMed ID: 24550397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The polypeptide part of human chorionic gonadotrophin affects the kinetics of alpha 6-sialylation of its N-linked glycans but does not alter the branch specificity of CMP-NeuAc:Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase.
    Nemansky M; Edzes HT; Wijnands RA; Van den Eijnden DH
    Glycobiology; 1992 Apr; 2(2):109-17. PubMed ID: 1606356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postnatal changes in sialylation of glycoproteins in rat liver.
    Oda-Tamai S; Kato S; Akamatsu N
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):179-85. PubMed ID: 1741745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.